ALEC
Alector, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.91
+3.24%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.24
- Revenue estimate
- $2.9M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.21
- EPS estimate
- -$0.23
- Revenue actual
- $3.3M
- Revenue estimate
- $1.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +20.0%
- Revenue beats (12Q)
- 9
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.23 | -$0.21 | Beat 8.12% | $3.3M |
| May 7, 2026 | -$0.35 | -$0.21 | Beat 40.00% | $1.0M |
| Feb 25, 2026 | -$0.39 | -$0.34 | Beat 12.82% | $6.2M |
| Nov 6, 2025 | -$0.42 | -$0.34 | Beat 19.05% | $3.3M |
| Aug 7, 2025 | -$0.45 | -$0.30 | Beat 33.33% | $7.9M |
| May 8, 2025 | -$0.44 | -$0.41 | Beat 6.82% | $3.7M |
| Feb 26, 2025 | -$0.61 | -$0.02 | Beat 96.72% | $54.2M |
| May 8, 2024 | -$0.48 | -$0.38 | Beat 20.83% | $15.9M |
| Feb 27, 2024 | -$0.80 | -$0.49 | Beat 38.75% | $15.2M |
| Aug 3, 2023 | -$0.82 | $0.02 | Beat 102.44% | $56.2M |
| May 4, 2023 | -$0.75 | -$0.55 | Beat 26.67% | $16.5M |
| Feb 28, 2023 | -$0.54 | -$0.63 | Miss -16.67% | $14.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026